Search Results

There are 10375 results for: content related to: Sustained response after a 2-year course of lamivudine treatment of hepatitis B e antigen-negative chronic hepatitis B

  1. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  2. Lamivudine salts with improved solubilities

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 6, June 2012, Pages: 2143–2154, Felipe T. Martins, Rudy Bonfilio, Magali B. De Araújo and Javier Ellena

    Version of Record online : 14 MAR 2012, DOI: 10.1002/jps.23117

  3. Management of viral hepatitis B

    Journal of Gastroenterology and Hepatology

    Volume 17, Issue s1, February 2002, Pages: S125–S145, CHUTIMA PRAMOOLSINSUP

    Version of Record online : 8 MAY 2002, DOI: 10.1046/j.1440-1746.17.s1.3.x

  4. You have free access to this content
    Chronic hepatitis B

    Hepatology

    Volume 45, Issue 2, February 2007, Pages: 507–539, Anna S. F. Lok and Brian J. McMahon

    Version of Record online : 26 JAN 2007, DOI: 10.1002/hep.21513

  5. Efficacy of lamivudine re-treatment for relapsed patients after an initial lamivudine therapy in HBeAg-positive chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 12, Issue 4, July 2005, Pages: 393–397, J. W. Shin, N. H. Park, J. H. Park, J. H. Park, I. D. Jeong, S-J. Bang, K. R. Joo and D. H. Kim

    Version of Record online : 14 MAR 2005, DOI: 10.1111/j.1365-2893.2005.00606.x

  6. Abstract Index

    Journal of Gastroenterology and Hepatology

    Volume 19, Issue s7, December 2004, Pages: A676–A868,

    Version of Record online : 3 DEC 2004, DOI: 10.1111/j.1440-1746.2004.03735.x

  7. Should lamivudine monotherapy be stopped or continued in patients infected with hepatitis B with favorable responses after more than 5 years of treatment?

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 34–42, Jung Hyun Kwon, Jeong Won Jang, Jong Young Choi, Chung-Hwa Park, Sun Hong Yoo, Si Hyun Bae and Seung Kew Yoon

    Version of Record online : 14 NOV 2012, DOI: 10.1002/jmv.23421

  8. Management of chronic hepatitis B virus infection: a new era of disease control

    Internal Medicine Journal

    Volume 36, Issue 2, February 2006, Pages: 100–113, G. C. Farrell and N. C. Teoh

    Version of Record online : 10 FEB 2006, DOI: 10.1111/j.1445-5994.2006.01027.x

  9. Viral Hepatitis

    Textbook of Hepatology: From Basic Science to Clinical Practice, Third Edition

    Mario Rizzetto, Fabien Zoulim, Pages: 819–956, 2008

    Published Online : 15 APR 2008, DOI: 10.1002/9780470691861.ch9a

  10. Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation

    Intervention Review

    The Cochrane Library

    Lior H Katz, Ran Tur-Kaspa, Daniel G Guy and Mical Paul

    Published Online : 7 JUL 2010, DOI: 10.1002/14651858.CD006005.pub2

  11. Lamivudine treatment of chronic hepatitis B

    Reviews in Medical Virology

    Volume 8, Issue 3, July/September 1998, Pages: 153–159, Geoffrey Dusheiko

    Version of Record online : 4 MAY 1999, DOI: 10.1002/(SICI)1099-1654(199807/09)8:3<153::AID-RMV228>3.0.CO;2-Y

  12. You have free access to this content
    A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial

    Hepatology

    Volume 47, Issue 3, March 2008, Pages: 844–853, Chiun Hsu, Chao A. Hsiung, Ih-Jen Su, Wei-Shou Hwang, Ming-Chung Wang, Sheng-Fung Lin, Tseng-Hsi Lin, Hui-Hua Hsiao, Ji-Hsiung Young, Ming-Chih Chang, Yu-Min Liao, Chi-Cheng Li, Hung-Bo Wu, Hwei-Fang Tien, Tsu-Yi Chao, Tsang-Wu Liu, Ann-Lii Cheng and Pei-Jer Chen

    Version of Record online : 27 DEC 2007, DOI: 10.1002/hep.22106

  13. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study

    Journal of Viral Hepatitis

    Volume 16, Issue 2, February 2009, Pages: 94–103, W.-M. Xu, Y.-T. Cui, L. Wang, H. Yang, Z.-Q. Liang, X.-M. Li, S.-L. Zhang, F.-Y. Qiao, F. Campbell, C.-N. Chang, S. Gardner and M. Atkins

    Version of Record online : 8 OCT 2008, DOI: 10.1111/j.1365-2893.2008.01056.x

  14. You have free access to this content
    AASLD Abstracts 895–1142

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 707A–816A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22644

  15. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update

    Liver International

    Volume 25, Issue 3, June 2005, Pages: 472–489, Yun-Fan Liaw, Nancy Leung, Richard Guan, George K.K. Lau, Ismail Merican, Geoff McCaughan, Edward Gane, Jia-Horng Kao, Masao Omata and for the Asian-Pacific consensus update working party on chronic hepatitis B

    Version of Record online : 21 MAY 2005, DOI: 10.1111/j.1478-3231.2005.01134.x

  16. Lamivudine/Zidovudine as a Combined Formulation Tablet: Bioequivalence Compared with Lamivudine and Zidovudine Administered Concurrently and the Effect of Food on Absorption

    The Journal of Clinical Pharmacology

    Volume 39, Issue 6, June 1999, Pages: 593–605, Dr. Katy H. P. Moore, Ms. Shuching Shaw, Dr. Aziz L. Laurent, Ms. Peggy Lloyd, Mr. Benjamin Duncan, Mr. David M. Morris, Mr. Michael J. O'Mara and Dr. Gary E. Pakes

    Version of Record online : 8 MAR 2013, DOI: 10.1177/00912709922008209

  17. You have free access to this content
    Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 3, March 2010, Pages: 583–590, Li-Jie Sun, Jian-Wu Yu, Yong-Hua Zhao, Peng Kang and Shu-Chen Li

    Version of Record online : 24 NOV 2009, DOI: 10.1111/j.1440-1746.2009.06089.x

  18. Tenofovir for the Treatment of Hepatitis B Virus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 10, October 2009, Pages: 1212–1227, Dr. Alice M. Jenh, Dr. Chloe L. Thio and Dr. Paul A. Pham

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.29.10.1212

  19. Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine

    Liver International

    Volume 31, Issue 5, May 2011, Pages: 667–675, Rifaat Safadi, Qing Xie, Yagang Chen, You-Kuan Yin, Lai Wei, Seong Gyu Hwang, Eli Zuckerman, Ji-Dong Jia and Patricia Lopez

    Version of Record online : 29 OCT 2010, DOI: 10.1111/j.1478-3231.2010.02360.x

  20. You have free access to this content
    A model-based approach for the evaluation of once daily dosing of lamivudine in HIV-infected children

    British Journal of Clinical Pharmacology

    Volume 77, Issue 5, May 2014, Pages: 852–860, Chiara Piana, Wei Zhao, Kimberly Adkison, David Burger, Evelyne Jacqz-Aigrain, Meindert Danhof and Oscar Della Pasqua

    Version of Record online : 22 APR 2014, DOI: 10.1111/bcp.12246